As NCI-H69 and NCI-H82 are the most commonly investigated SCLC cell lines and displayed rather weak constitutive activation, we further used these two cell lines to determine whether CXCL12 is able to directly activate JAK2/STAT3 signalling pathways in SCLC cells. The gene discussed is CXCL12; the disease is small cell lung carcinoma.